Christian Klein Selected Research

Christian Klein Research Topics

Disease

100	Neoplasms (Cancer) 04/2024 - 01/2004
14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 04/2013
11	Lymphoma (Lymphomas) 03/2024 - 02/2011
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2011
8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2004
6	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2012
6	Leukemia 12/2021 - 01/2018
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021 - 01/2015
5	Melanoma (Melanoma, Malignant) 01/2024 - 01/2015
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 10/2004
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021 - 01/2015
5	Arthritis (Polyarthritis) 12/2020 - 05/2015
5	Liver Diseases (Liver Disease) 01/2018 - 07/2003
4	Rheumatoid Arthritis 04/2024 - 05/2015
4	Experimental Arthritis 12/2020 - 03/2016
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024 - 01/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 01/2021
3	Cytokine Release Syndrome 11/2023 - 01/2022
3	Infections 10/2023 - 03/2003
3	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 12/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 10/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2013
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2016
3	Disease Progression 06/2021 - 03/2014
3	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020 - 01/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2015
3	Inflammation (Inflammations) 01/2017 - 08/2003
2	Multiple Sclerosis 04/2024 - 12/2017
2	Neuroinflammatory Diseases 01/2023 - 07/2013
2	Persistent Infection 01/2023 - 10/2022
2	Arteriovenous Malformations (Arteriovenous Malformation) 01/2023 - 01/2019
2	Adenocarcinoma 01/2023 - 01/2023
2	Virus Diseases (Viral Diseases) 10/2022 - 01/2018
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2022 - 12/2017
2	Bites and Stings (Sting) 01/2022 - 07/2015
2	Hypotension (Low Blood Pressure) 01/2022 - 01/2017
2	Hypoxia (Hypoxemia) 01/2022 - 12/2013
2	Wilms Tumor (Wilm's Tumor) 12/2021 - 01/2021
2	Wounds and Injuries (Trauma) 08/2021 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2020
2	Carcinogenesis 01/2020 - 09/2007
2	Neuroblastoma 12/2018 - 07/2013

Drug/Important Bio-Agent (IBA)

28	obinutuzumabIBA 02/2024 - 07/2012
27	Rituximab (Mabthera)FDA Link 04/2024 - 01/2011
26	AntibodiesIBA 02/2024 - 01/2011
26	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2005
21	Bispecific AntibodiesIBA 03/2024 - 10/2012
20	Monoclonal AntibodiesIBA 04/2024 - 01/2011
16	CytokinesIBA 11/2023 - 01/2011
15	Peptides (Polypeptides)IBA 01/2023 - 10/2004
14	AntigensIBA 01/2023 - 07/2015
9	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022 - 07/2015
8	Immunoglobulin G (IgG)IBA 01/2023 - 10/2012
7	cibisatamabIBA 01/2022 - 01/2016
7	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 07/2015
6	Carcinoembryonic AntigenIBA 02/2024 - 01/2016
6	Interleukin-2 (IL2)IBA 01/2022 - 01/2015
5	Chimeric Antigen ReceptorsIBA 04/2024 - 01/2015
5	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2016
5	LigandsIBA 03/2022 - 02/2005
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2003
5	Angiopoietin-2IBA 01/2020 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2011
4	venetoclaxIBA 01/2024 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2003
4	Amyloid (Amyloid Fibrils)IBA 01/2023 - 07/2013
4	Immunoglobulins (Immunoglobulin)IBA 11/2022 - 05/2011
3	glofitamabIBA 04/2024 - 01/2024
3	ofatumumab FDA Link 04/2024 - 10/2013
3	Monophenol Monooxygenase (Tyrosinase)IBA 01/2024 - 01/2015
3	ErbB Receptors (EGF Receptor)IBA 10/2022 - 11/2012
3	Phosphotransferases (Kinase)IBA 01/2022 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2003
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 12/2013
3	Neprilysin (Neutral Endopeptidase)IBA 12/2018 - 07/2013
2	ocrelizumabIBA 04/2024 - 01/2019
2	atezolizumabIBA 02/2024 - 11/2020
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2024 - 01/2017
2	ibrutinibIBA 10/2023 - 01/2023
2	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2022
2	Programmed Cell Death 1 ReceptorIBA 11/2022 - 01/2018
2	epidermal growth factor receptor VIIIIBA 10/2022 - 10/2019
2	Myelin Basic ProteinIBA 03/2022 - 12/2017
2	Indicators and Reagents (Reagents)IBA 01/2022 - 07/2015
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2022 - 01/2018
2	GalliumIBA 10/2021 - 01/2019
2	Histocompatibility Antigens Class IIBA 01/2021 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 11/2013
2	Granzymes (Granzyme)IBA 01/2021 - 12/2019
2	Amyloid beta-PeptidesIBA 01/2020 - 10/2004
2	Epithelial Cell Adhesion MoleculeIBA 10/2019 - 01/2015

Therapy/Procedure

45	Therapeutics 03/2024 - 02/2004
27	Immunotherapy 10/2023 - 08/2013
9	Drug Therapy (Chemotherapy) 01/2023 - 04/2013
4	Photochemotherapy (Photodynamic Therapy) 01/2023 - 12/2020
4	Liver Transplantation 05/2019 - 05/2011
3	Aftercare (After-Treatment) 12/2017 - 09/2016
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023 - 01/2021
2	Radiotherapy 01/2023 - 01/2023
2	Ligation 04/2020 - 07/2009